Entheon Biomedical (XCNQ:ENBI) Total Liabilities : C$0.06 Mil (As of Feb. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Total Liabilities?

Entheon Biomedical's Total Liabilities for the quarter that ended in Feb. 2025 was C$0.06 Mil.

Entheon Biomedical's quarterly Total Liabilities increased from Aug. 2024 (C$0.02 Mil) to Nov. 2024 (C$0.04 Mil) and increased from Nov. 2024 (C$0.04 Mil) to Feb. 2025 (C$0.06 Mil).

Entheon Biomedical's annual Total Liabilities declined from Nov. 2022 (C$0.16 Mil) to Nov. 2023 (C$0.09 Mil) and declined from Nov. 2023 (C$0.09 Mil) to Nov. 2024 (C$0.04 Mil).

Entheon Biomedical Total Liabilities Historical Data

The historical data trend for Entheon Biomedical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Total Liabilities Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Nov24

Total Liabilities

Get a 7-Day Free Trial

0.03

0.93

0.16

0.09

0.04

Entheon Biomedical Quarterly Data
	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Total Liabilities	Get a 7-Day Free Trial															0.05	0.04	0.02	0.04	0.06

Entheon Biomedical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Entheon Biomedical's Total Liabilities for the fiscal year that ended in Nov. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.017	+	(0	+	0.023
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.04

Total Liabilities	=	Total Assets (A: Nov. 2024 )	-	Total Equity (A: Nov. 2024 )
	=	0.185	-	0.145
	=	0.04

Entheon Biomedical's Total Liabilities for the quarter that ended in Feb. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.063	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.06

Total Liabilities	=	Total Assets (Q: Feb. 2025 )	-	Total Equity (Q: Feb. 2025 )
	=	0.563	-	0.5
	=	0.06

Entheon Biomedical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical Headlines

No Headlines